KA

Kalpesh Anilbhai Patel

Active Director Director DIN 11061972
DIN 11061972 First appointment Apr 2025
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Kalpesh Anilbhai Patel

Data last updated:

Kalpesh Anilbhai Patel is a Director at Aarogya Medikocart Private Limited (since 2025).

DIN 11061972
Primary Designation Director
First Appointment 24 Apr 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Aarogya Medikocart Private Limited U46497GJ2025PTC162015
Director24 Apr 20252025Active

Directorship timeline

Open interactive timeline →
Aarogya Medikocart Private Limited
Premium access

Shareholding and investment profile for Kalpesh Anilbhai Patel

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kalpesh Anilbhai Patel

Kalpesh Anilbhai Patel currently holds 1 directorship: Aarogya Medikocart Private Limited (Director, since 24 Apr 2025).

Kalpesh Anilbhai Patel was first appointed on 24 Apr 2025 as Director at Aarogya Medikocart Private Limited.

The current boards of Kalpesh Anilbhai Patel's companies include Alpesh Zaverbhai Patel (Aarogya Medikocart Private Limited), Bhavin Becharbhai Mangrolia (Aarogya Medikocart Private Limited), Mahesh Jethava (Aarogya Medikocart Private Limited), Mukesh Manharlal Gandhi (Aarogya Medikocart Private Limited), Sameer Narsinhbhai Patel (Aarogya Medikocart Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available